These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

35 related items for PubMed ID: 3236327

  • 1. Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes.
    Feher MD, Torrens DJ, Richmond W, Wadsworth J, Sever PS, Elkeles RS.
    J Hum Hypertens; 1988 Dec; 2(4):253-5. PubMed ID: 3236327
    [Abstract] [Full Text] [Related]

  • 2. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD, Henderson AD, Wadsworth J, Poulter C, Gelding S, Richmond W, Sever PS, Elkeles RS.
    J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects.
    Satia MC, Shukla ML, Goyal RK.
    Indian J Physiol Pharmacol; 1995 Jul; 39(3):237-41. PubMed ID: 8550116
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
    Hanon O, Giacomino A, Troy S, Bernaud C, Girerd X, Weber S.
    Ann Cardiol Angeiol (Paris); 2000 Oct; 49(7):390-6. PubMed ID: 12555491
    [Abstract] [Full Text] [Related]

  • 5. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
    Andersson PE, Johansson J, Berne C, Lithell H.
    J Hum Hypertens; 1994 Mar; 8(3):219-26. PubMed ID: 8006923
    [Abstract] [Full Text] [Related]

  • 6. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA.
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [Abstract] [Full Text] [Related]

  • 7. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H, Goyal RK.
    Indian Heart J; 2001 Dec; 53(2):172-6. PubMed ID: 11428472
    [Abstract] [Full Text] [Related]

  • 8. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C, Gibney J, Owens D, Collins P, Johnson A, Tomkin GH.
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [Abstract] [Full Text] [Related]

  • 9. Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients.
    Rouffy J, Jaillard J.
    Am J Med; 1984 Feb 27; 76(2A):105-8. PubMed ID: 6702861
    [Abstract] [Full Text] [Related]

  • 10. Beta-blockers, lipoproteins and non-insulin dependent diabetes.
    Feher MD, Rains SG, Richmond W, Torrens D, Wilson G, Wadsworth J, Sever PS, Elkeles RS.
    Postgrad Med J; 1988 Dec 27; 64(758):926-30. PubMed ID: 2908284
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of atenolol versus celiprolol on serum lipids and blood pressure in hyperlipidemic and hypertensive subjects.
    Dujovne CA, Eff J, Ferraro L, Goldstein RJ, Gotto AM, Hall WD, Harris WS, Held SJ, Herd A, Hunninghake DB.
    Am J Cardiol; 1993 Nov 15; 72(15):1131-6. PubMed ID: 8237801
    [Abstract] [Full Text] [Related]

  • 12. Effect of pindolol versus atenolol on lipid profile in hypertensive patients.
    Notghi A, Riemersma RA, Anderton JL, Oliver MF.
    Atherosclerosis; 1989 Jun 15; 77(2-3):215-20. PubMed ID: 2751753
    [Abstract] [Full Text] [Related]

  • 13. Abnormal lipid metabolism in treated hypertensive patients with non-insulin-dependent diabetes mellitus.
    Dall'Aglio E, Strata A, Reaven G.
    Am J Med; 1988 May 15; 84(5):899-903. PubMed ID: 3364449
    [Abstract] [Full Text] [Related]

  • 14. Hypotensive effect of the association atenolol-chlorthalidone in hypertensive diabetics.
    Gentile S, Coltorti M.
    J Int Med Res; 1984 May 15; 12(5):281-5. PubMed ID: 6500167
    [Abstract] [Full Text] [Related]

  • 15. Effect of manidipine as compared to atenolol on platelet aggregation in elderly patients with isolated systolic hypertension and type II diabetes mellitus.
    Mugellini A, Rinaldi A, Zoppi A, Lazzari P, Fogari E, Corradi L, Fogari R.
    J Cardiovasc Pharmacol; 2005 Apr 15; 45(4):310-3. PubMed ID: 15772518
    [Abstract] [Full Text] [Related]

  • 16. A 1-year follow-up study on the effect of atenolol on serum beta 2-microglobulin level in hypertensive diabetic patients.
    Koh H, Waki M, Nambu S.
    J Int Med Res; 1989 Apr 15; 17(2):162-7. PubMed ID: 2656332
    [Abstract] [Full Text] [Related]

  • 17. Effect of atenolol on serum beta 2-microglobulin level in hypertensive diabetic patients.
    Koh H, Nambu S, Ikeda M.
    J Clin Pharmacol; 1985 Apr 15; 25(3):230-2. PubMed ID: 3889077
    [Abstract] [Full Text] [Related]

  • 18. [Lipoprotein metabolism disorders in hypertension with a cerebral syndrome and their diagnostic value for medico-occupational expertise].
    Kukhtevich II, Mikhaĭliuk IA, Mitsenko MD.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Apr 15; 76(8):1153-6. PubMed ID: 973516
    [Abstract] [Full Text] [Related]

  • 19. Compositional changes in lipoproteins of subjects with non-insulin-dependent diabetes mellitus.
    Haffner SM.
    J Lab Clin Med; 1991 Aug 15; 118(2):109-10. PubMed ID: 1856574
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.